Glycerol Phenylbutyrate Liquid
Product Images NDC 70710-2193

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Glycerol Phenylbutyrate (NDC 70710-2193). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (97c20e1a 7e17 4311 9315 F492ff1b0261 01)

Chemical structure of Glycerol Phenylbutyrate, an oral liquid prescription drug. The diagram shows the molecular arrangement with phenyl and ester groups connected to a glycerol backbone.*

FDA Label Image

Figure-1 (97c20e1a 7e17 4311 9315 F492ff1b0261 02)

An illustration diagram showing the metabolic pathway of Glycerol Phenylbutyrate. It depicts conversion through ester hydrolysis by pancreatic lipases to phenylbutyric acid, then beta oxidation to phenylacetate, which conjugates with glutamine to form phenylacetylglutamine, followed by excretion in urine. Other metabolites include α-ketoglutarate, glutamate, and ammonium ions involved in glutamine synthesis.*

FDA Label Image

Image (97c20e1a 7e17 4311 9315 F492ff1b0261 03)

Line graph comparing mean normalized blood ammonia levels (µmol/L) over time for Glycerol phenylbutyrate and Sodium phenylbutyrate. The x-axis shows time points from 0 hour (fasting) to 24 hour (fasting), and the y-axis shows blood ammonia levels with error bars indicating standard error.*

FDA Label Image

Image (97c20e1a 7e17 4311 9315 F492ff1b0261 04)

Line chart depicting mean normalized blood ammonia levels (µmol/L) with standard error across a baseline and 12 monthly time points for glycerol phenylbutyrate treatment. The x-axis shows the timeline from baseline through month 12, and the y-axis measures blood ammonia concentration, with a legend identifying the data as glycerol phenylbutyrate.*

FDA Label Image

Image (97c20e1a 7e17 4311 9315 F492ff1b0261 05)

A line graph comparing mean normalized blood ammonia levels (μmol/L) over time (0, 6, 12, and 24 hours fasting) between Glycerol Phenylbutyrate and Sodium Phenylbutyrate. Glycerol Phenylbutyrate shows generally lower ammonia levels than Sodium Phenylbutyrate at each time point, with error bars representing standard error.*

FDA Label Image

Image (97c20e1a 7e17 4311 9315 F492ff1b0261 06)

A line graph depicting mean normalized blood ammonia levels (in µmol/L) with standard error bars over multiple time points, including baseline, fasting, and monthly intervals up to month 12, for Glycerol Phenylbutyrate. The x-axis lists time points, and the y-axis shows ammonia concentration.*

FDA Label Image

Container (97c20e1a 7e17 4311 9315 F492ff1b0261 07)

Label for Glycerol Phenylbutyrate Oral Liquid, 1.1 grams per mL, 25 mL bottle for oral use only. Distributed by Zydus Pharmaceuticals (USA) Inc., made in India. The label includes storage instructions and a barcode, with a designated unvarnished area of 30 by 20 mm.*

FDA Label Image

Carton (97c20e1a 7e17 4311 9315 F492ff1b0261 08)

Glycerol Phenylbutyrate Oral Liquid 1.1 grams per mL in a 25 mL bottle. Label includes storage instructions, dispensing guide for pharmacists, and dosage information. Distributed by Zydus Pharmaceuticals USA Inc. Made in India. Features NDC 70710-2193-5 and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.